{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:32:31Z","timestamp":1791149551861,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T00:00:00Z","timestamp":1562976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"German Federal Institute for Drugs and Mediccal Devices"},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["BE 4500\/3-1"],"award-info":[{"award-number":["BE 4500\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["ME 910\/2-1"],"award-info":[{"award-number":["ME 910\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["1749\/3-1"],"award-info":[{"award-number":["1749\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s15010-019-01342-1","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T14:02:49Z","timestamp":1563026569000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study"],"prefix":"10.1007","volume":"48","author":[{"given":"Wayan","family":"Philipps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Katrin","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Bluhmki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-7598","authenticated-orcid":false,"given":"Stephanie","family":"Padberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,13]]},"reference":[{"key":"1342_CR1","first-page":"263","volume":"20","author":"H Szweda","year":"2016","unstructured":"Szweda H, Jozwik M. Urinary tract infections during pregnancy\u2014an updated overview. Dev Period Med. 2016;20:263\u201372.","journal-title":"Dev Period Med."},{"key":"1342_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/01443615.2017.1370579","volume":"38","author":"K Kalinderi","year":"2018","unstructured":"Kalinderi K, Delkos D, Kalinderis M, Athanasiadis A, Kalogiannidis I. Urinary tract infection during pregnancy: current concepts on a common multifaceted problem. J Obstet Gynaecol. 2018;38:448\u201353. \nhttps:\/\/doi.org\/10.1080\/01443615.2017.1370579\n\n.","journal-title":"J Obstet Gynaecol"},{"key":"1342_CR3","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1345\/aph.1D630","volume":"38","author":"J Le","year":"2004","unstructured":"Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother. 2004;38:1692\u2013701. \nhttps:\/\/doi.org\/10.1345\/aph.1D630","journal-title":"Ann Pharmacother"},{"key":"1342_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.clp.2005.05.006","volume":"32","author":"P Mittal","year":"2005","unstructured":"Mittal P, Wing DA. Urinary tract infections in pregnancy. Clin Perinatol. 2005;32:749\u201364. \nhttps:\/\/doi.org\/10.1016\/j.clp.2005.05.006\n\n.","journal-title":"Clin Perinatol"},{"key":"1342_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ucl.2015.05.004","volume":"42","author":"AP Glaser","year":"2015","unstructured":"Glaser AP, Schaeffer AJ. Urinary tract infection and bacteriuria in pregnancy. Urol Clin N Am. 2015;42:547\u201360. \nhttps:\/\/doi.org\/10.1016\/j.ucl.2015.05.004\n\n.","journal-title":"Urol Clin N Am"},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/MOU.0000000000000365","volume":"27","author":"J Kranz","year":"2017","unstructured":"Kranz J, Helbig S, Mandraka F, Schmidt S, Naber KG. The revival of old antibiotics for treatment of uncomplicated urinary tract infections in the era of antibiotic stewardship. Curr Opin Urol. 2017;27:127\u201332. \nhttps:\/\/doi.org\/10.1097\/MOU.0000000000000365\n\n.","journal-title":"Curr Opin Urol"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s40265-013-0143-y","volume":"73","author":"GM Keating","year":"2013","unstructured":"Keating GM. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs. 2013;73:1951\u201366. \nhttps:\/\/doi.org\/10.1007\/s40265-013-0143-y\n\n.","journal-title":"Drugs."},{"key":"1342_CR8","unstructured":"Deutsche Gesellschaft f\u00fcr Urologie e. V. (DGU). Interdisziplin\u00e4re S3 Leitlinie Leitlinie unkomplizierter Epidemiologie, Diagnostik, Therapie, Management ambulant Epidemiologie, Diagnostik, Therapie Pr\u00e4vention und Management, bakterieller, ambulant erworbener Harnwegsinfektionen bei Patienten erworbener Harnwegsinfektionen bei erwachsenen Patienten Deutsche Gesellschaft f\u00fcr Urologie; 2017. pp.\u00a01\u2013254."},{"key":"1342_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijgo.2011.03.014","volume":"114","author":"TA Usta","year":"2011","unstructured":"Usta TA, Dogan O, Ates U, Yucel B, Onar Z, Kaya E. Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. Int J Gynaecol Obstet. 2011;114:229\u201333. \nhttps:\/\/doi.org\/10.1016\/j.ijgo.2011.03.014\n\n.","journal-title":"Int J Gynaecol Obstet"},{"key":"1342_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10096-009-0805-6","volume":"28","author":"A Estebanez","year":"2009","unstructured":"Estebanez A, Pascual R, Gil V, Ortiz F, Santibanez M, Perez BC. Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. Eur J Clin Microbiol Infect Dis. 2009;28:1457\u201364. \nhttps:\/\/doi.org\/10.1007\/s10096-009-0805-6\n\n.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00192-006-0190-y","volume":"18","author":"O Bayrak","year":"2007","unstructured":"Bayrak O, Cimentepe E, Inegoel I, Atmaca AF, Duvan CI, Koc A, et al. Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy? Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:525\u20139. \nhttps:\/\/doi.org\/10.1007\/s00192-006-0190-y\n\n.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct."},{"key":"1342_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0924-8579(00)00351-4","volume":"17","author":"S Krcmery","year":"2001","unstructured":"Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001;17:279\u201382. \nhttps:\/\/doi.org\/10.1016\/S0924-8579(00)00351-4\n\n.","journal-title":"Int J Antimicrob Agents"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000222044","volume":"23","author":"L Ferreres","year":"1977","unstructured":"Ferreres L, Paz M, Martin G, Gobernado M. New studies on placental transfer of fosfomycin. Chemotherapy. 1977;23:175\u20139. \nhttps:\/\/doi.org\/10.1159\/000222044\n\n.","journal-title":"Chemotherapy"},{"key":"1342_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000222040","volume":"23","author":"WM Kirby","year":"1977","unstructured":"Kirby WM. Pharmacokinetics of fosfomycin. Chemotherapy. 1977;23:141\u201351. \nhttps:\/\/doi.org\/10.1159\/000222040\n\n.","journal-title":"Chemotherapy"},{"key":"1342_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00228-017-2351-y","volume":"74","author":"K Dathe","year":"2018","unstructured":"Dathe K, Schaefer C. Drug safety in pregnancy: the German Embryotox institute. Eur J Clin Pharmacol. 2018;74:171\u20139. \nhttps:\/\/doi.org\/10.1007\/s00228-017-2351-y\n\n.","journal-title":"Eur J Clin Pharmacol"},{"key":"1342_CR16","unstructured":"EUROCAT\u2014European Surveillance of Congenital Anomalies. EUROCAT Guide 1.4: Instruction for the registration of congenital anomalies. EUROCAT Central Registry, University of Ulster; 2018."},{"key":"1342_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","volume":"26","author":"C Schaefer","year":"2008","unstructured":"Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome\u2014methodological considerations. Reprod Toxicol. 2008;26:36\u201341. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2008.05.064\n\n.","journal-title":"Reprod Toxicol"},{"key":"1342_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","volume":"26","author":"R Meister","year":"2008","unstructured":"Meister R, Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2014analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol. 2008;26:31\u20135. \nhttps:\/\/doi.org\/10.1016\/j.reprotox.2008.06.006\n\n.","journal-title":"Reprod Toxicol"},{"key":"1342_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4710","author":"T Bluhmki","year":"2019","unstructured":"Bluhmki T, Fietz A-K, Stegherr R, Beck E, Padberg S, Beyersmann J, et al. Multistate methodology improves risk assessment under time-varying drug intake\u2014a new view on pregnancy outcomes following coumarin exposure. Pharmacoepidemiol Drug Saf. 2019. \nhttps:\/\/doi.org\/10.1002\/pds.4710\n\n.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"1342_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/pds.1357","volume":"16","author":"S Suissa","year":"2007","unstructured":"Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16:241\u20139. \nhttps:\/\/doi.org\/10.1002\/pds.1357\n\n.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1342_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-2035-4","volume-title":"Competing risks and multistate models with R","author":"J Beyersmann","year":"2012","unstructured":"Beyersmann J, Allignol A, Schumacher M. Competing risks and multistate models with R. 1st ed. New York: Springer; 2012.","edition":"1"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/s-0029-1241833","volume":"214","author":"M Voigt","year":"2010","unstructured":"Voigt M, Rochow N, Hesse V, Olbertz D, Schneider KT, Jorch G. Short communication about percentile values of body measures of newborn babies. Z Geburtshilfe Neonatol. 2010;214:24\u20139. \nhttps:\/\/doi.org\/10.1055\/s-0029-1241833\n\n.","journal-title":"Z Geburtshilfe Neonatol"},{"key":"1342_CR23","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661\u201379. \nhttps:\/\/doi.org\/10.1002\/sim.6607\n\n.","journal-title":"Stat Med"},{"key":"1342_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/1082-989X.9.4.403","volume":"9","author":"DF McCaffrey","year":"2004","unstructured":"McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods. 2004;9:403\u201325. \nhttps:\/\/doi.org\/10.1037\/1082-989X.9.4.403\n\n.","journal-title":"Psychol Methods"},{"key":"1342_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken: Wiley; 2002.","edition":"2"},{"key":"1342_CR26","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"2004","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken: Wiley; 2004."},{"issue":"4","key":"1342_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i04","volume":"38","author":"A Allignol","year":"2011","unstructured":"Allignol A, Schumacher M, Beyersmann J. Empirical transition matrix of multi-state models: the etm package. J Stat Softw. 2011;38(4):1\u201315.","journal-title":"J Stat Softw."},{"key":"1342_CR28","unstructured":"Therneau TM. A package for survival analysis in S. version 2.44-1.1. 2019. \nhttps:\/\/cran.r-project.org\/package=survival\n\n. Accessed 05 July 2019."},{"key":"1342_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.7164\/antibiotics.32.607","volume":"32","author":"T Koeda","year":"1979","unstructured":"Koeda T, Moriguchi M. Effect of fosfomycin-Na on reproductive performance of rats. II. Fertility test (author\u2019s transl). Jpn J Antibiot. 1979;32:164\u201370.","journal-title":"Jpn J Antibiot."},{"key":"1342_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajog.2017.12.231","volume":"219","author":"CM Chu","year":"2018","unstructured":"Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219:40\u201351. \nhttps:\/\/doi.org\/10.1016\/j.ajog.2017.12.231\n\n.","journal-title":"Am J Obstet Gynecol"},{"key":"1342_CR31","first-page":"1","volume":"3","author":"L Michelim","year":"2016","unstructured":"Michelim L, Bosi GR, Comparsi E. Urinary tract infection in pregnancy: review of clinical management. J Clin Nephrol Res. 2016;3:1\u20137.","journal-title":"J Clin Nephrol Res."},{"key":"1342_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","volume":"18","author":"R Raz","year":"2012","unstructured":"Raz R. Fosfomycin: an old\u2014new antibiotic. Clin Microbiol Infect. 2012;18:4\u20137. \nhttps:\/\/doi.org\/10.1111\/j.1469-0691.2011.03636.x\n\n.","journal-title":"Clin Microbiol Infect"},{"key":"1342_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF01710022","volume":"20","author":"DS Reeves","year":"1992","unstructured":"Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection. 1992;20:313\u20136. \nhttps:\/\/doi.org\/10.1007\/BF01710022\n\n.","journal-title":"Infection"},{"key":"1342_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000472874","volume":"13","author":"L De Cecco","year":"1987","unstructured":"De Cecco L, Ragni N. Urinary tract infections in pregnancy: monuril single-dose treatment versus traditional therapy. Eur Urol. 1987;13:108\u201313.","journal-title":"Eur Urol"},{"key":"1342_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000238818","volume":"36","author":"S Zinner","year":"1990","unstructured":"Zinner S. Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy. Chemotherapy. 1990;36:50\u20132. \nhttps:\/\/doi.org\/10.1159\/000238818\n\n.","journal-title":"Chemotherapy"},{"key":"1342_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1471-0528.1998.tb10234.x","volume":"105","author":"LV Wilton","year":"1998","unstructured":"Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD. The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol. 1998;105:882\u20139. \nhttps:\/\/doi.org\/10.1111\/j.1471-0528.1998.tb10234.x\n\n.","journal-title":"Br J Obstet Gynaecol"},{"key":"1342_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/phar.1649","volume":"35","author":"PB Bookstaver","year":"2015","unstructured":"Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35:1052\u201362. \nhttps:\/\/doi.org\/10.1002\/phar.1649\n\n.","journal-title":"Pharmacotherapy."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01342-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-019-01342-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-019-01342-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T23:08:51Z","timestamp":1594508931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-019-01342-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s15010-019-01342-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,13]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Ethics Committee of the Charit\u00e9 Universit\u00e4tsmedizin Berlin (EA4\/119\/17) and registered at the German Clinical Trials Register (DRKS00013159).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}